Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133302
Status:
TERMINATED
Last Update Posted:
2007-01-18
First Post:
2005-08-22
Brief Title:
Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkins Lymphoma JCOG9809
Sponsor:
Japan Clinical Oncology Group
Organization:
Japan Clinical Oncology Group
Study Overview
Official Title:
Randomized Phase III Study of Standard CHOP S-CHOP Versus Biweekly CHOP Bi-CHOP in Aggressive Non-Hodgkins Lymphoma JCOG9809
Status:
TERMINATED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to investigate the clinical benefit of the dose intensified regimen Bi-CHOP in comparison to standard CHOP for advanced intermediate or high grade non-Hodgkins lymphoma NHL
Detailed Description:
The purpose of JCOG9809 was to determine whether treatment results of aggressive NHL could be improved by shortening intervals of CHOP chemotherapy with the prophylactic use of G-CSF The primary endpoint was Progression Free Survival PFS and the planned accrual was 450 Until December 2002 323 patients with advanced aggressive NHL were randomized to standard CHOP arm CHOP x 8 every three weeks and biweekly CHOP arm CHOP x 8 every two weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C000000036 | None | None | None |